![Richard Collin](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Network origin in Richard Collin first degree
Entity | Entity type | Industry | |
---|---|---|---|
Subsidiary | Medical Specialties | 3 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Richard Collin via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
ID Biomedical Corp.
![]() ID Biomedical Corp. Medical SpecialtiesHealth Technology ID Biomedical Corp. develops gene-based disease testing and subunit vaccines. It conducts research, development, manufacturing, sales, and marketing from its facilities in Canada and in the United States. The company was founded in 1991 and is headquartered in Vancouver, Canada. | Medical Specialties | Corporate Officer/Principal | |
TRANSITION THERAPEUTICS INC | Medical Specialties | Corporate Officer/Principal | |
The Trustees of Columbia University in The City of New York | College/University | Undergraduate Degree | |
University of Cambridge | College/University | Graduate Degree | |
Queen's University | College/University | Doctorate Degree | |
Massachusetts Institute of Technology | College/University | Doctorate Degree | |
GlaxoSmithKline, Inc.
![]() GlaxoSmithKline, Inc. Pharmaceuticals: MajorHealth Technology GlaxoSmithKline, Inc. manufactures and markets pharmaceutical products. The company develops medicines to prevent infections that cause serious medical problems such as respiratory illnesses, diabetes, viral control, infections, and central nervous system disorders. The company is headquartered in Mississauga, Canada. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Active Pass Pharmaceuticals, Inc.
![]() Active Pass Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Active Pass Pharmaceuticals, Inc. develops drugs for infectious diseases. It engages in the development of drugs that inhibit ABC transporters. The firm also provides portfolio of therapeutic programs, including age-related macular degeneration, travelers' diarrhea, and lipid disorders. The company was founded by Peter B Reiner in 1998 and is headquartered in Vancouver, Canada. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Biodextris, Inc.
![]() Biodextris, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Clean Cells SAS, Biodextris, Inc. is a contract research organization based in Laval, Canada. The Canadian company provides analytical, process development, and CMC consulting services for vaccines and biologics in the clinical stages of development. Biodextris' expertise, facilities, and quality systems support clients in navigating a path from R&D to early-phase clinical trials. The company was founded in 2015 by Joseph Zimmermann, who has been the CEO since then. On May 05, 2021, Biodextris was acquired by Clean Cells SAS. | Miscellaneous Commercial Services | Chief Executive Officer | |
Inspirevax, Inc. | Chief Executive Officer |
Statistics
International
Canada | 8 |
United States | 3 |
United Kingdom | 2 |
Sectoral
Health Technology | 5 |
Consumer Services | 4 |
Finance | 2 |
Commercial Services | 2 |
Operational
Corporate Officer/Principal | 3 |
Doctorate Degree | 2 |
Director/Board Member | 2 |
Independent Dir/Board Member | 2 |
Chief Executive Officer | 2 |
Most connected contacts
Insiders | |
---|---|
Joseph Zimmermann | 8 |
Bruce P. Connop | 4 |
Mahendra Pallapothu | 1 |
- Stock Market
- Insiders
- Richard Collin
- Company connections